In a phase IIIb trial conducted at @ centers worldwide between April @ and November @ , otherwise healthy women aged @-@ years requesting contraception were randomized to daily oral administration of E ( @ ) V/DNG ( n = @ ) or EE/LNG ( n = @ ) for three @-daycycles .